Myovant Sciences Ltd.
Myovant Sciences Ltd. (MYOV) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · MYOV · as of Dec 31, 2024
Ownership Breakdown
1
Institutional Holders
$27
Total Inst. Value
97.26M
Shares Outstanding
freeFloat 52.29%
1
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
MYOV largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
HUNTINGTON NATIONAL BANK pharmaceutical preparations | 1 | 0.00% | 0.00% | $27,000 | Feb 12, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
MYOV insider trading · insider activity
Source: SEC Form 4
2
Buy transactions
57
Sell transactions
0.04
Buy/Sell ratio
$8M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Valente Nancy director | Mar 10, 2023 | D-Return | 3,673 | $27.00 | $99.2K | 0 | Form 4 ↗ |
Valente Nancy director | Mar 10, 2023 | D-Return | 36,892 | $22.71 | $837.8K | 0 | Form 4 ↗ |
POTTER MYRTLE S director | Mar 10, 2023 | D-Return | 58,608 | $7.65 | $448.4K | 0 | Form 4 ↗ |
POTTER MYRTLE S director | Mar 10, 2023 | D-Return | 21,603 | $21.47 | $463.8K | 0 | Form 4 ↗ |
POTTER MYRTLE S director | Mar 10, 2023 | D-Return | 3,673 | $27.00 | $99.2K | 0 | Form 4 ↗ |
POTTER MYRTLE S director | Mar 10, 2023 | D-Return | 21,096 | $22.71 | $479.1K | 0 | Form 4 ↗ |
POTTER MYRTLE S director | Mar 10, 2023 | D-Return | 45,000 | $26.17 | $1.18M | 0 | Form 4 ↗ |
Merendino Lauren Chief Commercial Officer | Mar 10, 2023 | D-Return | 21,791 | $27.00 | $588.4K | 147.7K | Form 4 ↗ |
Merendino Lauren Chief Commercial Officer | Mar 10, 2023 | D-Return | 147,747 | — | — | 0 | Form 4 ↗ |
Merendino Lauren Chief Commercial Officer | Mar 10, 2023 | D-Return | 123,300 | $17.88 | $2.20M | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Myovant Sciences Ltd. (MYOV) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 47.71%, while retail and public investors account for the remaining 52.29%.
The largest institutional shareholder of Myovant Sciences Ltd. is HUNTINGTON NATIONAL BANK, holding approximately 1 shares — equal to — of outstanding shares — as of December 31, 2024.
A total of 1 institutional investors currently hold MYOV stock, with a combined institutional value of approximately $27 as of the most recent 13F filing period.
Frequently asked questions
MYOV ownershipMyovant Sciences Ltd. (MYOV) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is HUNTINGTON NATIONAL BANK with a — stake. Company insiders hold 47.71%. Data sourced from SEC Form 13F as of December 31, 2024.